Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Journal of Pharmacological and Toxicological Methods
|
September 20, 2005
Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized rat
Scott R Armstrong, Julia L McCullough, David T Beattie
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 4, 2013
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist
Pamela R Tsuruda, Ross G Vickery, Daniel D Long, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
September 9, 2011
The inability of tegaserod to affect platelet aggregation and coronary artery tone at supratherapeutic concentrations
Deborah L Higgins, Mike P Ero, Michelle Loeb, et al.
Journal of Bacteriology
|
February 17, 2009
Functional genomics of Enterococcus faecalis: multiple novel genetic determinants for biofilm formation in the core genome
Katie S Ballering, Christopher J Kristich, Suzanne M Grindle, et al.
ACS Omega
|
August 5, 2024
Bioluminescent Assay for the Quantification of Cellular Glycogen Levels
Donna Leippe, Rebeca Choy, Gediminas Vidugiris, et al.
Neuropharmacology
|
March 12, 2011
5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment
Fei Shen, Jacqueline A M Smith, Ray Chang, et al.
Journal of Inflammation (London, England)
|
December 12, 2017
Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy
David T Beattie, M Teresa Pulido-Rios, Fei Shen, et al.
Anesthesiology
|
April 26, 2012
AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis
Talmage D Egan, Shinju Obara, Thomas E Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2017
Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists
Lan Jiang, David T Beattie, John R Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 13, 2013
Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties
R Murray McKinnell, Scott R Armstrong, David T Beattie, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Journal of Pharmacological and Toxicological Methods
|
September 20, 2005
Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized rat
Scott R Armstrong, Julia L McCullough, David T Beattie
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 4, 2013
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist
Pamela R Tsuruda, Ross G Vickery, Daniel D Long, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
September 9, 2011
The inability of tegaserod to affect platelet aggregation and coronary artery tone at supratherapeutic concentrations
Deborah L Higgins, Mike P Ero, Michelle Loeb, et al.
Journal of Bacteriology
|
February 17, 2009
Functional genomics of Enterococcus faecalis: multiple novel genetic determinants for biofilm formation in the core genome
Katie S Ballering, Christopher J Kristich, Suzanne M Grindle, et al.
ACS Omega
|
August 5, 2024
Bioluminescent Assay for the Quantification of Cellular Glycogen Levels
Donna Leippe, Rebeca Choy, Gediminas Vidugiris, et al.
Neuropharmacology
|
March 12, 2011
5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment
Fei Shen, Jacqueline A M Smith, Ray Chang, et al.
Journal of Inflammation (London, England)
|
December 12, 2017
Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy
David T Beattie, M Teresa Pulido-Rios, Fei Shen, et al.
Anesthesiology
|
April 26, 2012
AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis
Talmage D Egan, Shinju Obara, Thomas E Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2017
Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists
Lan Jiang, David T Beattie, John R Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 13, 2013
Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties
R Murray McKinnell, Scott R Armstrong, David T Beattie, et al.
Page
of 2